Work

Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.9022

Authors: Hira Rizvi, Andrew J. Plodkowski, Megan Tenet, Darragh Halpenny, Niamh Long, Jennifer L. Sauter, Francisco Sanchez-Vega, Walid K Chatila, Nikolaus Schultz, Marc Ladanyi, Kathryn Cecilia Arbour, Jamie E. Chaft, Matthew David Hellmann

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891548652

Cites:

Cited by: 8

Related to: 10